| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Alfredo Fusco | |
| Claudio Arra | |||
| Daniela D'Angelo | |||
| Marco De Martino | |||
| P2860 | cites work | The USP8 mutational status may predict long-term remission in patients with Cushing's disease | Q89348567 |
| circOMA1-Mediated miR-145-5p Suppresses Tumor Growth of Nonfunctioning Pituitary Adenomas by Targeting TPT1 | Q91355354 | ||
| RPSAP52 lncRNA is overexpressed in pituitary tumors and promotes cell proliferation by acting as miRNA sponge for HMGA proteins | Q91932951 | ||
| Pseudogenes: Are They “Junk” or Functional DNA? | Q22065389 | ||
| HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity | Q24293207 | ||
| A Pituitary-Derived MEG3 Isoform Functions as a Growth Suppressor in Tumor Cells | Q24299283 | ||
| Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis | Q24607308 | ||
| MicroRNA expression profile of bromocriptine-resistant prolactinomas | Q87449075 | ||
| Stratifin regulates stabilization of receptor tyrosine kinases via interaction with ubiquitin-specific protease 8 in lung adenocarcinoma | Q89032142 | ||
| Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y | Q24633159 | ||
| Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs | Q24673619 | ||
| Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans | Q24679314 | ||
| The H19 Long non-coding RNA in cancer initiation, progression and metastasis - a proposed unifying theory | Q26780223 | ||
| High mobility group a proteins as tumor markers | Q26853205 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| HMGA1-pseudogenes and cancer | Q28072498 | ||
| Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation | Q28253227 | ||
| The prevalence of pituitary adenomas: a systematic review | Q28273848 | ||
| In vivo modulation of Hmgic reduces obesity | Q28586839 | ||
| Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C | Q28588994 | ||
| HMGA1-pseudogene overexpression contributes to cancer progression | Q28608654 | ||
| HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs | Q28652432 | ||
| Landscape of transcription in human cells | Q29547467 | ||
| Vertebrate pseudogenes | Q29618328 | ||
| Pituitary incidentaloma: an endocrine society clinical practice guideline. | Q30353104 | ||
| Characterization of Gpr101 expression and G-protein coupling selectivity | Q33241539 | ||
| Hmga1/Hmga2 double knock-out mice display a "superpygmy" phenotype | Q33612796 | ||
| Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma. | Q33622368 | ||
| Transgenic mice expressing a truncated form of the high mobility group I-C protein develop adiposity and an abnormally high prevalence of lipomas. | Q33896677 | ||
| Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q. | Q33897694 | ||
| Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations | Q34030921 | ||
| Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas | Q34135253 | ||
| Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis | Q34237969 | ||
| Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1. | Q34273288 | ||
| Differential expression of microRNAs in GH-secreting pituitary adenomas | Q34471255 | ||
| Advances in understanding pituitary tumors | Q34660143 | ||
| Recurrent gain-of-function USP8 mutations in Cushing's disease | Q35146226 | ||
| EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas | Q35578652 | ||
| The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease | Q35813265 | ||
| Animal models of pituitary neoplasia | Q36486988 | ||
| The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop | Q36557324 | ||
| Roles of HMGA proteins in cancer | Q37001370 | ||
| The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development | Q37332559 | ||
| USP8 is a novel target for overcoming gefitinib resistance in lung cancer | Q37476722 | ||
| Role of the high mobility group A proteins in the regulation of pituitary cell cycle | Q37706867 | ||
| In search of a prognostic classification of endocrine pituitary tumors | Q38212659 | ||
| MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro | Q38323442 | ||
| The high mobility group protein HMG I(Y) is required for NF-kappa B-dependent virus induction of the human IFN-beta gene | Q38324299 | ||
| Methyl-CpG binding column-based identification of nine genes hypermethylated in colorectal cancer | Q38336376 | ||
| Rasd1 is an estrogen-responsive immediate early gene and modulates expression of late genes in rat anterior pituitary cells | Q38694305 | ||
| Long non-coding RNA C5orf66-AS1 is downregulated in pituitary null cell adenomas and is associated with their invasiveness | Q38705928 | ||
| HMGA1-pseudogene expression is induced in human pituitary tumors. | Q38884465 | ||
| Mir-23b and miR-130b expression is downregulated in pituitary adenomas | Q39010323 | ||
| Aip regulates cAMP signalling and GH secretion in GH3 cells | Q39148181 | ||
| Overview of the 2017 WHO Classification of Pituitary Tumors | Q39190559 | ||
| Nonfunctioning pituitary adenomas: association of Ki-67 and HMGA-1 labeling indices with residual tumor growth | Q39266698 | ||
| The Dimensions, Dynamics, and Relevance of the Mammalian Noncoding Transcriptome | Q39324991 | ||
| PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis | Q39422281 | ||
| Down-regulation of Wee1 kinase by a specific subset of microRNA in human sporadic pituitary adenomas | Q39674297 | ||
| Analysis of epidermal growth factor receptor and activated epidermal growth factor receptor expression in pituitary adenomas and carcinomas | Q40564623 | ||
| Thyroid cell transformation requires the expression of the HMGA1 proteins | Q40722563 | ||
| Mutations in the deubiquitinase gene USP8 cause Cushing's disease | Q41716700 | ||
| HMGA1P7-pseudogene regulates H19 and Igf2 expression by a competitive endogenous RNA mechanism | Q42364945 | ||
| The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis. | Q42809960 | ||
| E2F1-mediated human POMC expression in ectopic Cushing's syndrome | Q42856188 | ||
| USP8 mutation in Cushing's disease | Q43200816 | ||
| Low aryl hydrocarbon receptor-interacting protein expression is a better marker of invasiveness in somatotropinomas than Ki-67 and p53. | Q44054768 | ||
| From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal | Q45054086 | ||
| Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors | Q45219910 | ||
| Mechanisms for growth factor-induced pituitary tumor transforming gene-1 expression in pituitary folliculostellate TtT/GF cells. | Q46001664 | ||
| Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice | Q46517052 | ||
| The HMGA1 Pseudogene 7 Induces miR-483 and miR-675 Upregulation by Activating Egr1 through a ceRNA Mechanism. | Q47136898 | ||
| HMGA2 cooperates with either p27(kip1) deficiency or Cdk4(R24C) mutation in pituitary tumorigenesis. | Q47382950 | ||
| Somatic USP8 mutations are frequent events in corticotroph tumor progression causing Nelson's tumor | Q47690666 | ||
| Ubiquitin-specific protease 8 is a novel prognostic marker in early-stage lung adenocarcinoma. | Q48096086 | ||
| Pituitary adenoma predisposition caused by germline mutations in the AIP gene. | Q51585727 | ||
| EGFR Induces E2F1-Mediated Corticotroph Tumorigenesis. | Q52738992 | ||
| USP8 Mutations in Pituitary Cushing Adenomas-Targeted Analysis by Next-Generation Sequencing. | Q52806299 | ||
| Circular RNAs function as ceRNAs to regulate and control human cancer progression. | Q53176299 | ||
| Expression of the long non-coding RNA H19 and MALAT-1 in growth hormone-secreting pituitary adenomas and its relationship to tumor behavior. | Q53421523 | ||
| 14-3-3-dependent inhibition of the deubiquitinating activity of UBPY and its cancellation in the M phase. | Q53532387 | ||
| Expression of the long non-coding RNAs MEG3, HOTAIR, and MALAT-1 in non-functioning pituitary adenomas and their relationship to tumor behavior. | Q54225798 | ||
| Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas. | Q54678305 | ||
| Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells. | Q54694108 | ||
| Recent Updates on the Diagnosis and Management of Cushing's Syndrome. | Q55387370 | ||
| Clinical characteristics and surgical outcome in USP8-mutated human adrenocorticotropic hormone-secreting pituitary adenomas | Q57470855 | ||
| Identification of recurrent USP48 and BRAF mutations in Cushing's disease | Q58793747 | ||
| SOM230, A New Somatostatin Analogue, Is Highly Effective in the Therapy of Growth Hormone/Prolactin-Secreting Pituitary Adenomas | Q59122469 | ||
| The High Mobility Group A2 gene is amplified and overexpressed in human prolactinomas | Q59122644 | ||
| The impairment of the High Mobility Group A (HMGA) protein function contributes to the anticancer activity of trabectedin | Q60322887 | ||
| High Expression of Ubiquitin-Specific Protease 8 (USP8) Is Associated with Poor Prognosis in Patients with Cervical Squamous Cell Carcinoma. | Q64898836 | ||
| Identification of epidermal growth factor mRNA-expressing cells in the mouse anterior pituitary | Q73576466 | ||
| Localization of Epidermal Growth Factor (EGF) and Epidermal Growth Factor Receptor (EGFr) in Human Pituitary Adenomas and Nontumorous Pituitaries: An Immunocytochemical Study | Q74453793 | ||
| Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas | Q81160827 | ||
| AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression | Q83657187 | ||
| Pathogenesis of pituitary tumors | Q83667492 | ||
| Increased expression of HMGA1 correlates with tumour invasiveness and proliferation in human pituitary adenomas | Q84202548 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P577 | publication date | 2019-09-04 | |
| P1433 | published in | Cancers | Q27722963 |
| P1476 | title | Emerging Role of USP8, HMGA, and Non-Coding RNAs in Pituitary Tumorigenesis | |
| P478 | volume | 11 |
Search more.